Endocrinologia

M-A | Terapia medicamentosa antitireoidiana na gestação e risco de anomalias congênitas.

11 Jul, 2022 | 13:42h

Antithyroid drug therapy in pregnancy and risk of congenital anomalies: Systematic review and meta-analysis – Clinical Endocrinology

 

---

M-A | Químicos perturbadores endocrinológicos e risco de diabetes melito gestacional.

11 Jul, 2022 | 13:34h

Endocrine-disrupting chemicals and the risk of gestational diabetes mellitus: a systematic review and meta-analysis – Environmental Research

 

---

Análise post-hoc | Os inibidores de SGLT2 são capazes de reduzir o risco de nefrolitíase?

8 Jul, 2022 | 11:14h

Empagliflozin and Decreased Risk of Nephrolithiasis: A Potential New Role for SGLT2 Inhibition? – The Journal of Clinical Endocrinology & Metabolism

 

---

Análise post-hoc | Os inibidores de SGLT2 são capazes de reduzir o risco de hiperuricemia e gota?

8 Jul, 2022 | 11:12h

Uric acid and sodium-glucose cotransporter-2 inhibition with empagliflozin in heart failure with reduced ejection fraction: the EMPEROR-reduced trial – European Heart Journal

 

---

Diretriz sobre diagnóstico e tratamento da doença arterial periférica.

7 Jul, 2022 | 12:16h

Australian guideline on diagnosis and management of peripheral artery disease: part of the 2021 Australian evidence-based guidelines for diabetes-related foot disease – Journal of Foot and Ankle Research

Conteúdos relacionados:

Australian guideline on management of diabetes-related foot infection: part of the 2021 Australian evidence-based guidelines for diabetes-related foot disease – Journal of Foot and Ankle Research

Australian guideline on wound classification of diabetes-related foot ulcers: part of the 2021 Australian evidence-based guidelines for diabetes-related foot disease

Australian guideline on wound healing interventions to enhance healing of foot ulcers: part of the 2021 Australian evidence-based guidelines for diabetes-related foot disease

Australian guideline on offloading treatment for foot ulcers: part of the 2021 Australian evidence-based guidelines for diabetes-related foot disease

---

Revisão sistemática | Seguimento de longo prazo para verificar a morbidade entre mulheres com histórico de diabetes melito gestacional.

7 Jul, 2022 | 11:56h

Long-term follow-up on morbidity among women with a history of gestational diabetes mellitus: a systematic review – The Journal of Clinical Endocrinology & Metabolism

---

Principais estudos publicados em 2021 relacionados à prevenção primária de doença cardiovascular aterosclerótica.

6 Jul, 2022 | 11:17h

Highlights in ASCVD Primary Prevention for 2021 – Journal of the American Heart Association

---

Diretriz prática sobre o início e a titulação da insulina basal na Ásia.

6 Jul, 2022 | 11:11h

Practical Guidance on Basal Insulin Initiation and Titration in Asia: A Delphi-Based Consensus – Diabetes Therapy

---

Análise agrupada de estudos clínicos placebo-controlados | Segurança da empagliflozina em pacientes com diabetes tipo 2 e doença renal crônica.

4 Jul, 2022 | 11:38h

Safety of Empagliflozin in Patients With Type 2 Diabetes and Chronic Kidney Disease: Pooled Analysis of Placebo-Controlled Clinical Trials – Diabetes Care

---

Estudo de coorte nacional | Segurança da cirurgia bariátrica em pacientes com eventos coronarianos agudos prévios ou insuficiência cardíaca.

22 Jun, 2022 | 21:18h

Safety of bariatric surgery in patients with previous acute coronary events or heart failure: nationwide cohort study – BJS Open

 

Comentário no Twitter

#Bariatric surgery improves metabolic health of patients, but what are the risks if they have had MI before surgery?

National dataset matched 16000 pts🇸🇪
Heart dis assoc w/🔼 cardiac events post op, plus 🔼risk of SBO and stricture.#SoMe4Surgery https://t.co/iHsZiHIgdG pic.twitter.com/v2SXMpcZd3

— BJS Open (@BjsOpen) June 17, 2022

 

---